Aripiprazole Injection
347 interactions 801 cited referencesAripiprazole extended-release injection (Abilify Maintena, Aristada, Aristada Initio) is used alone or in combination with other aripiprazole preparations to treat schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Aripiprazole ext… Read the full Aripiprazole Injection drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Contraindicated
Aripiprazole Injection Bepridil An increased risk of QT interval prolongation Details Aripiprazole Injection Bromopride Increased risk of extrapyramidal reactions Details Aripiprazole Injection Cisapride Propulsid® Increased risk of QT interval prolongation Details Aripiprazole Injection Dronedarone Multaq Increased risk of QT interval prolongation Details Aripiprazole Injection Ensitrelvir Increased CYP3A substrates exposure and an increased risk of CYP3A substrates-related adverse effects Details Aripiprazole Injection Fluconazole Diflucan Increased ARIPiprazole or ARIPiprazole lauroxil (prodrug of ARIPiprazole) exposure and an increased risk of QT interval prolongati... Details Aripiprazole Injection Isocarboxazid Marplan An increased risk of CNS depression Details Aripiprazole Injection Ketoconazole Extina Increased ARIPiprazole exposure and an increased risk of QT interval prolongation Details Aripiprazole Injection Levoketoconazole Recorlev An increased risk of QT interval prolongation and torsades pointes, an increased CYP3A4 substrate exposure and an increased risk o... Details Aripiprazole Injection Mavorixafor Xolremdi Increased CYP2D6 substrate exposure, increased risk of CYP2D6-related adverse events and an increased risk of QT interval prolonga... Details Aripiprazole Injection Mesoridazine Increased risk of CNS depression and an increased risk of QT interval prolongation Details Aripiprazole Injection Metoclopramide An increased risk of extrapyramidal reactions and neuroleptic malignant syndrome Details Aripiprazole Injection Pimozide Increased risk of CNS depression and an increased risk of QT interval prolongation Details Aripiprazole Injection Piperaquine Increased exposure of CYP3A4 substrates and an increased risk of QT interval prolongation Details Aripiprazole Injection Posaconazole Noxafil Increased ARIPiprazole exposure and an increased risk of QT interval prolongation Details Aripiprazole Injection Saquinavir An increased risk of QT interval prolongation Details Aripiprazole Injection Sparfloxacin An increased risk of QT interval prolongation Details Aripiprazole Injection Terfenadine An increased risk of QT interval prolongation Details Aripiprazole Injection Thioridazine An increased risk of QT interval prolongation Details Aripiprazole Injection Ziprasidone Geodon An increased risk of QT interval prolongation and an increased risk of CNS depression DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist